GLAXO
Invest with MTF
Invest Now
Invest in GlaxoSmithKline Pharmaceuticals with 3.24X leverage
Performance
- Low
- ₹2,579
- High
- ₹2,627
- 52 Week Low
- ₹2,087
- 52 Week High
- ₹3,516
- Open Price₹2,591
- Previous Close₹2,597
- Volume87,738
- 50 DMA₹2,496.35
- 100 DMA₹2,559.32
- 200 DMA₹2,627.04
Investment Returns
- Over 1 Month + 11.01%
- Over 3 Month + 5.01%
- Over 6 Month -5.99%
- Over 1 Year + 29.02%
Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!
GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 43.2
- PEG Ratio
- 2.3
- Market Cap Cr
- 44,107
- P/B Ratio
- 25.8
- Average True Range
- 77.42
- EPS
- 59.37
- Dividend Yield
- 1.6
- MACD Signal
- 31.31
- RSI
- 60.39
- MFI
- 64.95
GlaxoSmithKline Pharmaceuticals Financials
GlaxoSmithKline Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,603.60
+
6.3
(0.24%)
- Bearish Moving Average 4
- Bullish Moving Average 12
- 20 Day
- ₹2,513.88
- 50 Day
- ₹2,496.35
- 100 Day
- ₹2,559.32
- 200 Day
- ₹2,627.04
Resistance and Support
2603.2
- R3 2,675.40
- R2 2,651.20
- R1 2,627.40
- S1 2,579.40
- S2 2,555.20
- S3 2,531.40
GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
GlaxoSmithKline Pharmaceuticals F&O
About GlaxoSmithKline Pharmaceuticals
- NSE Symbol
- GLAXO
- BSE Symbol
- 500660
- Managing Director
- Mr. B Akshikar
- ISIN
- INE159A01016
Similar Stocks to GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals FAQs
GlaxoSmithKline Pharmaceuticals share price is ₹2,603 As on 18 February, 2026 | 01:38
The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹44106.5 Cr As on 18 February, 2026 | 01:38
The P/E ratio of GlaxoSmithKline Pharmaceuticals is 43.2 As on 18 February, 2026 | 01:38
The PB ratio of GlaxoSmithKline Pharmaceuticals is 25.8 As on 18 February, 2026 | 01:38
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.